Measles in pregnancy: A review;Rougeole chez la femme enceinte : mise au point

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 41, Issue 3, 2012, Pages 209-218

  Guillet, M ^a   Vauloup Fellous, C ^a   Cordier, A G ^b   Grangeot Keros, L ^a   Benoist, G ^c   Nedellec, S ^b   Benachi, A ^b   Freymuth, F ^c   Picone, O ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Management; Measles; Pregnancy; Pregnant women

Indexed keywords

MEASLES VACCINE;

ARTICLE; HUMAN; IMMUNIZATION; MEASLES; NEUROLOGIC DISEASE; PNEUMONIA; PREGNANCY; PREGNANT WOMAN; PREMATURITY; RISK FACTOR; SPONTANEOUS ABORTION;

EID: 84860255773     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2012.01.008     Document Type: Review

References (67)

1. F. Freymuth, J. Dina, I. Parent du Châtelet, B. Mourez, D. Waku-Kouomou, and A. Vabret La rougeole et son virus Virologie. 15 2011 6 22
2. J.F. Enders, and T.C. Peebles Propagation in tissue cultures of cytopathogenic agents from patients with measles Proc Soc Exp Biol Med. 86 1954 277 286
3. D. Griffin Measles virus Virology F 5th ed. 2007 Lippincott Williams and Wilkins Philadelphia
4. J.O. Lloyd-Smith, S.J. Schreiber, P.E. Kopp, and W.M. Getz Superspreading and the effect of individual variation on disease emergence Nature. 438 2005 355 359
5. A.S. Monto Interrupting the transmission of respiratory tract infections: theory and practice Clin Infect Dis 28 1999 200 204
6. J. Stokes Jr., C.M. Reilly, E.B. Buynak, and M.R. Hilleman Immunologic studies of measles Am J Hyg. 74 1961 293 303
7. P.E. Christensen, H. Schmidt, O. Jensen, H.O. Bang, V. Andersen, and B. Jordal An epidemic of measles in Southern Greenland, 1951. I. Measles in virgin soil Acta Med Scand. 144 1953 313 322
8. I. Parent du Châtelet, D. Floret, D. Antona, and D. Lévy-Bruhl Measles resurgence in France in 2008, a preliminary report Euro Surveill. 14 2009 [Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 19215722 ]
9. I. Parent du Châtelet, D. Antona, F. Freymuth, M. Muscat, F. Halftermeyer-Zhou, and C. Maine Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010 Euro Surveill. 15 2010 [Available from: http://www.ncbi.nlm.nih.gov/pubmed/20843472 ]
10. INVS. Épidémie de rougeole en France ; actualisation des données au 20 mai 2011. 2011. Available from: http://www.invs.sante.fr/ surveillance/rougeole/Point-rougeole-200511.pdf.
11. F.C. Robbins Measles: clinical features. Pathogenesis, pathology and complications Am J Dis Child. 103 1962 266 273
12. S. Krugman, S. Katz, A. Gershon, and C. Wilfert Measles (rubeola) Infectious diseases of children 1992 Mosby Year Book St Louis p. 223-45
13. S. Krugman Further-attenuated measles vaccine: characteristics and use Rev Infect Dis 5 1983 477 481
14. H. Koplik The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membrane Arch Pediatr. 79 1962 162 165
15. D.W. Suringa, L.J. Bank, and A.B. Ackerman Role of measles virus in skin lesions and Koplik's spots N Engl J Med. 283 1970 1139 1142
16. C. Sabella Measles: not just a childhood rash Cleve Clin J Med. 77 2010 207 213
17. R.T. Perry, and N.A. Halsey The clinical significance of measles: a review J Infect Dis 189 2004 S4 S16
18. R.M. Barkin Measles mortality. Analysis of the primary cause of death Am J Dis Child. 129 1975 307 309
19. B.P. Quiambao, S.R. Gatchalian, P. Halonen, M. Lucero, L. Sombrero, and F.J. Paladin Coinfection is common in measles-associated pneumonia Pediatr Infect Dis J 17 1998 89 93
20. M.K. Makhene, and P.S. Diaz Clinical presentations and complications of suspected measles in hospitalized children Pediatr Infect Dis J 12 1993 836 840
21. W.H. Mason, L.A. Ross, J. Lanson, and H.T. Wright Jr. Epidemic measles in the postvaccine era: evaluation of epidemiology, clinical presentation and complications during an urban outbreak Pediatr Infect Dis J 12 1993 42 48
22. D.L. Miller Frequency of complications of measles, 1963: report on a national inquiry by the Public Health Laboratory Service in collaboration with the Society of Medical Officers of Health Br Med J. 2 1964 75 78
23. CDC Measles - Los Angeles Country, California, 1988. MMWR Morb Mortal Wkly Rep 1989;38:49-52 [57].
24. R.T. Johnson, D.E. Griffin, R.L. Hirsch, J.S. Wolinsky, S. Roedenbeck, and I. Lindo de Soriano Measles encephalomyelitis - clinical and immunologic studies N Engl J Med 310 1984 137 141
25. J.L. Sever Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis Rev Infect Dis 5 1983 467 473
26. CDC Subacute sclerosing panencephalitis surveillance - United States. MMWR Morb Mortal Wkly Rep 1982;31:585-8.
27. R. Detels, J.A. Brody, J. McNew, and A.H. Edgar Further epidemiological studies of subacute sclerosing panencephalitis Lancet. 2 1973 11 14
28. N.A. Halsey, J.F. Modlin, J.T. Jabbour, L. Dubey, D.L. Eddins, and D.D. Ludwig Risk factors in subacute sclerosing panencephalitis: a case-control study Am J Epidemiol. 111 1980 415 424
29. R.D. Wong, and M.B. Goetz Clinical and laboratory features of measles in hospitalized adults Am J Med. 95 1993 377 383
30. R.G. Feachem, and M.A. Koblinsky Interventions for the control of diarrhoeal diseases among young children: measles immunization Bull World Health Organ. 61 1983 641 652
31. D.C. Morley Measles in the developing world Proc R Soc Med 67 1974 1112 1115
32. F.T. Koster, G.C. Curlin, K.M. Aziz, and A. Haque Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh Bull World Health Organ 59 1981 901 908
33. J. Bennett, H. Whittle, B. Samb, B. Cisse, F. Simondon, and P. Aaby Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal Int J Epidemiol. 28 1999 147 151
34. S. Krugman, J.P. Giles, A.M. Jacobs, and H. Friedman Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin Am J Dis Child 103 1962 353 363
35. S. Krugman, J.P. Giles, A.M. Jacobs, and H. Friedman Studies with a further attenuated live measles-virus vaccine Pediatrics. 31 1963 919 928
36. M.B. Edmonson, D.G. Addiss, J.T. McPherson, J.L. Berg, S.R. Circo, and J.P. Davis Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population JAMA. 263 1990 2467 2471
37. H.C. Whittle, P. Aaby, B. Samb, H. Jensen, J. Bennett, and F. Simondon Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa Lancet. 353 1999 98 102
38. F.R. Smith, A.S. Curran, K.A. Raciti, and F.L. Black Reported measles in persons immunologically primed by prior vaccination J Pediatr 101 1982 391 393
39. F.A. Lievano, M.J. Papania, R.F. Helfand, R. Harpaz, L. Walls, and R.S. Katz Lack of evidence of measles virus shedding in people with inapparent measles virus infections J Infect Dis 189 2004 S165 S170
40. R.L. Atmar, J.A. Englund, and H. Hammill Complications of measles during pregnancy Clin Infect Dis. 14 1992 217 226
41. J.E. Eberhart-Phillips, P.D. Frederick, R.C. Baron, and L. Mascola Measles in pregnancy: a descriptive study of 58 cases Obstet Gynecol. 82 1993 797 801
42. M.E. Ali, and H.M. Albar Measles in pregnancy: maternal morbidity and perinatal outcome Int J Gynaecol Obstet. 59 1997 109 113
43. B. Muhlbauer, L.M. Berns, and A. Singer Congenital measles - 1982 Isr J Med Sci 19 1983 987 988
44. G. Manikkavasagan, and M. Ramsay The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review J Obstet Gynaecol. 29 2009 572 575
45. K. Zwiauer, E. Forstenpointner, T. Popow-Kraupp, E. Hauser, and K.A. Jellinger Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection Lancet. 345 1995 1124
46. Y. Sawaishi, T. Abe, T. Yano, K. Ishikawa, and G. Takada SSPE following neonatal measles infection Pediatr Neurol 20 1999 63 65
47. D. Cruzado, V. Masserey-Spicher, L. Roux, J. Delavelle, F. Picard, and C.A. Haenggeli Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection Eur J Pediatr. 161 2002 438 441
48. M. Dasopoulou, and A. Covanis Subacute sclerosing panencephalitis after intrauterine infection Acta Paediatr. 93 2004 1251 1253
49. H. Campbell, N. Andrews, K.E. Brown, and E. Miller Review of the effect of measles vaccination on the epidemiology of SSPE Int J Epidemiol. 36 2007 1334 1348
50. Direction générale de la Santé, Comité technique des vaccinations. Guide des vaccinations. 2008. p. 309-18.
51. INVS Le calendrier des vaccinations et les recommandations vaccinales 2011 selon l'avis du Haut Conseil de la santé publique Bull Epidemiol Hebd. 10-11 2011 10 11
52. V. Gajdos, F. Dubos, Y. Gillet, H. Haas, C. Sana, and E. Caulin Âge effectif de la vaccination RRO en France en 2007 Bull Epidemiol Hebd. 34 2009 365
53. Ministre de la Santé et des Sports. Circulaire no DGS/RI1/2009/334 du 4 novembre 2009 relative à la transmission obligatoire de données individuelles à l'autorité sanitaire en cas de rougeole et la mise en œuvre de mesures préventives autour d'un cas ou de cas groupés. 2009. Available from: http://www.sante.gouv.fr/IMG/ pdf/09-334t0pdf.pdf.
54. L.E. Markowitz, S.R. Preblud, P.E. Fine, and W.A. Orenstein Duration of live measles vaccine-induced immunity Pediatr Infect Dis J 9 1990 101 110
55. H.A. Gans, L.L. Yasukawa, A. Alderson, M. Rinki, R. DeHovitz, and J. Beeler Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States J Infect Dis 190 2004 83 90
56. L. Fonteneau, J. Urcun, J. Guthmann, N. Guignon, D. Lévy-Bruhl, and J. Herbet Couverture vaccinale des enfants de 11 ans scolarisés en CM2, France, 2004-2005 Bulletin Epidémiologique Hebdomadaire. 51-52 2008 493 497
57. INVS. Couverture vaccinale rougeole. Available from: http://www.invs. sante.fr/display/?doc=surveillance/rougeole.
58. Ministre de la Santé et des Solidarités. Plan d'élimination de la rougeole et de la rubéole congénitale en France 2005-2010. 2005.
59. M.A. Riddell, D. Chibo, H.A. Kelly, M.G. Catton, and C.J. Birch Investigation of optimal specimen type and sampling time for detection of measles virus RNA during a measles epidemic J Clin Microbiol 39 2001 375 376
60. OMS. Élimination de la rougeole et de la rubéole et prévention de la rubéole congénitale - Plan stratégique pour la région européenne de l'OMS, 2005-2010. 2005.
61. I. Barrabeig, A. Rovira, C. Rius, P. Muñoz, N. Soldevila, and J. Batalla Effectiveness of measles vaccination for control of exposed children Pediatr Infect Dis J 30 2011 78 80
62. AFSSAPS, Haute Autorité de santé. Prophylaxie des sujets à risque aprs exposition à un cas confirmé de rougeoles. 2001. Available from: http://www.sante.gouv.fr/IMG/pdf/IG-AfssapsHAS-Mars2011. pdf.
63. A. Endo, H. Izumi, M. Miyashita, K. Taniguchi, O. Okubo, and K. Harada Current efficacy of postexposure prophylaxis against measles with immunoglobulin J Pediatr. 138 2001 926 928
64. CDC Post-exposure prophylaxis, isolation and quarantine to control an import-associated measles outbreak - Iowa 2004 MMWR Morb Mortal Wkly Rep. 53 2004 969 977
65. V. Sheppeard, B. Forssman, M.J. Ferson, C. Moreira, S. Campbell-Lloyd, and D.E. Dwyer The effectiveness of prophylaxis for measles contacts in NSW N S W Public Health Bull. 20 2009 81 85
66. A. Shoda, M. Hayashi, N. Takayama, K. Oshima, M. Nishikawa, and T. Okazaki Maternal screening and postpartum vaccination for measles infection in Japan: a cohort study BJOG. 118 2011 88 92
67. Haut Conseil de la Santé Publique. Avis relatif à la problématique de la rougeole chez la femme enceinte. 23 mai 2011.